Scientific Content

Structured Monitoring for Early Detection of Fabry Progression

Renal Outcomes After Switching to Agalsidase Beta: A Single-Center Analysis

Dupilumab for Patients with AFRS

Guidelines for RSV prevention with Nirsevimab

Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract infections in infants and young children. Nirsevimab is a long-acting monoclonal antibody that provides passive immunization against RSV, offering protection throughout the RSV season with a single dose

RSV Shield: WEQAYA's Strategy on Nirsevimab Implementation

This video explains WEQAYA's strategy on Nirsevimab Implementation

An easy guide to use Nirsevimab

ADCT – Atopic Dermatitis Control Tool

Pre-Ramadan assessment and Risk calculation for people with diabetes who want to fast during Ramadan

Rare Disease Academy 2.0/ Spotting the Signs: A guide to Early Diagnosis and a Timely Refferals

Spot early signs of Pompe, Gaucher, Fabry, ASMD & MPS I. A Sanofi guide to early diagnosis and timely referrals for rare lysosomal storage disorders.

MS pulse - Tracking the hidden drivers of MS progression

Advancing the Standard of Care: Addressing Progression in MS

An evidence-based exploration of the current MS landscape, focusing on the pathophysiology of Progression Independent of Relapse Activity (PIRA). This module examines the clinical significance of disability accumulation and the remaining unmet needs in long-term patient management.